Sulfation of apomorphine by human sulfotransferases: evidence of a major role for the polymorphic phenol sulfotransferase, SULT1A1

References

• ARGIOLAS, A. and HEDLUND, H., 2001, The pharmacology and clinical pharmacokinetics of apomorphine SL. BJU International, 88(Suppl 3), 18–21.
   PubMed Web of Science ®Google Scholar
• BRADFORD, M. M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein—dye binding. Analytical Biochemistry, 72, 248–254.
   PubMed Web of Science ®Google Scholar
• COUGHTRIE, M. W. H., 2002, Sulfation through the looking glass — recent advances in sulfotransferase research for the curious. Pharmacogenomics Journal, 2, 297–308.
   PubMedGoogle Scholar
• COUGHTRIE, M. W. H., GILISSEN, R. A. H. J., SHEK, B., STRANGE, R. C., FRYER, A. A., JONES, P. W. and BAMBER, D. E., 1999, Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochemical Journal, 337, 45–49.
   Google Scholar
• DAJANI, R., CLEASBY, A., NEU, M., WONACOTT, A. J., JHuri, H., HOOD, A. M., Mom, S., HERSEY, A., TASKINEN, J., COOKE, R. M., MANCHEE, G. R. and COUGHTRIE, M. W. H., 1999a, X-ray crystal structure of human dopamine sulfotransferase, SULT1A3: Molecular modelling and QSAR analysis demonstrate a molecular basis for sulfotransferase substrate specificity. Journal of Biological Chemistry, 274, 37862–37868.
   PubMed Web of Science ®Google Scholar
• DAJANI, R., HOOD, A. M. and COUGHTRIE, M. W. H., 1998, A single amino acid, G1u14.6, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3. Molecular Pharmacology, 54, 942–948.
   PubMed Web of Science ®Google Scholar
• DAJANI, R., SHARP, S., GRAHAM, S., BETHELL, S. S., COOKE, R. M., JAMIESON, D. J. and COUGHTRIE, M. W. H., 1999b, Kinetic properties of human dopamine sulfotransferase (SULT1A3) expressed in prokaryotic and eukaryotic systems: comparison with the recombinant enzyme purified from Escherichia coli. Protein Expression and Purification, 16, 11–18.
   PubMed Web of Science ®Google Scholar
• DOOLEY, T. P., Haldeman-CAHILL, R., JOINER, J. and WILBORN, T. W., 2000, Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells. Biochemical and Biophysical Research Communications, 277, 236–245.
   Google Scholar
• FOLDES, A. and MEEK, J. L., 1973, Rat brain phenolsulfotransferase — partial purification and some properties. Biochimica et Biophysica Acta, 327, 365–374.
   PubMed Web of Science ®Google Scholar
• GANCHER, S. T., NUTT, J. G. and WOODWARD, W. R., 1991, Absorption of apomorphine by various routes in Parkinsonism. Movement Disorders, 6, 212–216.
   PubMed Web of Science ®Google Scholar
• GANCHER, S. T., WOODWARD, W. R., BOUCHER, B. and NUTT, J. G., 1989, Peripheral pharmacokinetics of apomorphine in humans. Annals of Neurology, 26, 232–238.
   PubMed Web of Science ®Google Scholar
• HEROUX, J. A., FALANY, C. N. and ROTH, J. A., 1989, Immunological characterization of human phenol sulfotransferase. Molecular Pharmacology, 36, 29–33.
   PubMed Web of Science ®Google Scholar
• HONMA, W., SHIMADA, M., SASANO, H., OZAWA, S., MIYATA, M., NAGATA, K., IKEDA, T. and YAMAZOE, Y., 2002, Phenol sulfotransferase, ST1A3, as the main enzyme catalyzing sulfation of troglitazone in human liver. Drug Metabolism and Disposition, 30, 944–949.
   PubMed Web of Science ®Google Scholar
• JANKOVIC, J. and MARSDEN, D., 1998, Therapeutic strategies in Parkinson's disease. In J. Jankovic and E. Tolosa (eds), Parkinson's Disease and Movement Disorders, 3rd edn (Baltimore: Williams & Wilkins), pp. 191–220.
   Google Scholar
• JONES, A. L., ROBERTS, R. C. and COUGHTRIE, M. W. H., 1993, The human phenolsulfotransferase polymorphism is determined by the level of expression of the enzyme protein. Biochemical Journal, 296, 287–290.
   PubMed Web of Science ®Google Scholar
• O'SULLIVAN, J. D. and LEES, A. J., 1999, Use of apomorphine in Parkinson's disease. Hospital Medicine, 60, 816–820.
   Google Scholar
• PIETZ, K., HAGELL, P. and ODIN, P., 1998, Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up. Journal of Neurology, Neurosurgery and Psychiatry, 65, 709-716. RAFTOGIANIS, R. B., 2001, Human sulfotransferases and cellular response to estrogens and antiestrogens. Drug Metabolism Reviews, 33(Suppl 1), 10.
   Google Scholar
• RAFTOGIANIS, R. B., WOOD, T. C., OTTERNESS, D. M., Van LOON, J. A. and WEINSHILBOUM, R. M., 1997, Phenol sulfotransferase pharmacogenetics in humans: Association of common SULT1A1 alleles with TS PST phenotype. Biochemical and Biophysical Research Communications, 239, 298–304.
   PubMed Web of Science ®Google Scholar
• RAFTOGIANIS, R. B., WOOD, T. C. and WEINSHILBOUM, R. M., 1999, Human phenol sulfotransferases SULT1A2 and SULT1A1. Genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochemical Pharmacology, 58, 605–616.
   PubMed Web of Science ®Google Scholar
• RICHARD, K., HUME, R., KAPTEIN, E., STANLEY, E. L., VISSER, T. J. and COUGHTRIE, M. W. H., 2001, Sulfation of thyroid hormone and dopamine during human development — ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung and brain. Journal of Clinical Endocrinology and Metabolism, 86, 2734–2742.
   PubMed Web of Science ®Google Scholar
• RUBIN, G. L., HARROLD, A. J., MILLS, J. A., FALANY, C. N. and COUGHTRIE, M. W. H., 1999, Regulation of sulfotransferase expression in the endometrium during the menstrual cycle, by oral contraceptives and during early pregnancy. Molecular Human Reproduction, 5, 995–1002.
   PubMed Web of Science ®Google Scholar
• RUBIN, G. L., SHARP, S., JONES, A. L., GLATT, H., MILLS, J. A. and COUGHTRIE, M. W. H., 1996, Design, production and characterisation of antibodies discriminating between the phenol- and monoamine-sulphating forms of human phenol sulphotransferase. Xenobiotica, 26, 1113–1119.
   PubMed Web of Science ®Google Scholar
• STANLEY, E. L., HUME, R., VISSER, T. J. and COUGHTRIE, M. W. H., 2001, Differential expression of sulfotransferase enzymes involved in thyroid hormone metabolism during human placental development. Journal of Clinical Endocrinology and Metabolism, 86, 5944–5955.
   PubMed Web of Science ®Google Scholar
• STROTT, C. A., 2002, Sulfonation and molecular action. Endocrine Reviews, 23, 703–732.
   PubMed Web of Science ®Google Scholar
• TASKINEN, J., ETHELL, B., LAUTALA, P., HOOD, A. M., BURCHELL, B. and COUGHTRIE, M. W. H., 2003, Conjugation of catechols by recombinant human sulfotransferases, UDP-glucuronosyltrans-ferases and soluble catechol 0-methyltransferase. Drug Metabolism and Disposition, 31, 1187–1197.
   PubMed Web of Science ®Google Scholar
• VIETRI, M., VAGLINI, F., CANTINI, R. and PACIFICI, G. M., 2003, Quercetin inhibits the sulfation of R(—)-apomorphine in human brain. International Journal of Clinical Pharmacology and Therapeutics, 41, 30–35.
   PubMed Web of Science ®Google Scholar
• VIETRI, M., VAGLINI, F., PIETRABISSA, A., SPISNI, R., MOSCA, F. and PACIFICI, G. M., 2002, Sulfation of R(—)-apomorphine in the human liver and duodenum, and its inhibition by mefenamic acid, salicylic acid and quercetin. Xenobiotica, 32, 587–594.
   PubMed Web of Science ®Google Scholar